Mindray Receives CE Marking Approval for HIV and HBV CLIA Test Kits

Food and Healthcare Press Releases Wednesday October 25, 2017 08:04
SHENZHEN, China--25 Oct--PRNewswire/InfoQuest
Mindray is the first and only Chinese medical device company to have passed the assessment of the European Directive 98/79/EC (IVDD) for List A tests.

Mindray announced it has received CE Marking certificates issued by TUV SUD, a global certification body for medical devices, for its HIV and HBV (HBsAg, Anti-HBs, Anti-HBc, HBeAg, and Anti-HBe) CLIA (Chemiluminescence Immunoassay) test kits. Mindray becomes the first and only Chinese medical device company to receive List A CE Marking for infectious disease tests.

"Infectious disease tests are one of the most complicated and stringent CLIA assays due to complexity of samples and the existence of mutations. Over the last few years Mindray's R&D team has been committed to tackling the difficulties and challenges. Now we have finally obtained CE certifications for these List A assays," Mr. Haitao Huang, Vice President of Mindray Group, said at the CE certification announcement.

"We have applied a number of patented technologies in the infectious disease assays to shorten the window period and reduce the endogenous interference of samples from pregnant women, the elderly, and patients with hepatic or renal diseases," added Mr. Zhaoyang Li, General Manager of Mindray In-Vitro Diagnostics Business Unit. Behind Mindray's high quality products are its globally integrated innovation platform and world-class quality control system. Every year Mindray invests around 10% of its revenues in R&D to drive development of safe and dependable medical applications resulting in solutions that are trusted by customers worldwide and certified with international standards such as FDA and CE Marking.

Mindray 4th-generation HIV assay

The Mindray CL-series HIV assay is a Chemiluminescent Immunoassay for the simultaneous qualitative determination of both HIV p24 antigen prior to seroconversion, and antibodies to HIV-1 (including Group M & O) and HIV-2 in human serum or plasma. This 4th-generation HIV assay shortens the detection window and improves detection sensitivity of early HIV infection. It may be used as an aid in the diagnosis of HIV-1/HIV-2 infection and as a screening test for donated blood.

Mindray:

Mindray is a leading global developer of medical devices and solutions, dedicated to making better healthcare more accessible to humanity. Since its foundation in 1991, Mindray has been exclusively focused on the medical industry in the fields of Patient Monitoring & Life Support, In-Vitro Diagnostics, and Medical Imaging.   www.mindray.com/en


Latest Press Release

Menarini Ricerche Announces New Positive Results in Acute Myeloid Leukemia Cell Lines for MEN1112/OBT357 at the 60th Annual SIC Meeting

Menarini Ricerche will present tomorrow, September 20th, at the 60th Annual Meeting of the Italian Cancer Society (SIC), new preclinical data showing that pre-treatment with 5-Azacytidine and Decitabine enhances the Antibody-dependent cellular...

Experts Call for Improved Identification of #High Burden# Rosacea Patients in Everyday Practice

- Additional analysis of global survey data reveals quality of life is impacted by several factors extending beyond severity of rosacea alone Additional analysis of a global survey conducted and presented earlier this year, as an expert-authored report...

BookDoc collaborates with Chow Tai Fook: Get more rewards by staying active together with Chow Tai Fook

Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia by healthcare network in giving more rewards to BookDoc users for maintaining an active healthy lifestyle. Users can now enjoy discounts and redeem...

MEDICAL WINGS THAILAND BASED AIR AMBULANCE OPERATOR ACHIEVES FULL ACCREDITATION FROM CAMTS AND CAMTS EU AND BECOMES THE FIRST OPERATOR IN ASIA TO ACHIEVE THE #DUAL ACCREDITATION

Medical Wings, the air ambulance division of Siam Land Flying Company, a subsidiary company of Charoen Pokphand Group (C.P. Group), is proud to achieve full re-accreditation of its existing CAMTS approval as well as attaining the new CAMTS EU...

Photo Release: CGH Group Hospital held the event Happy Life with Healthy Bone and Joints Seminar in Yangon, Myanmar.

CGH Group Hospital recently held a live health talk in Yangon, Myanmar to highlight the important health issues on bone and joints for all Myanmar people. A team of medical experts led by Dr. Wanchai Sirisereewan (4th from left), CGH's Orthopedic Surgeon...

Related Topics